Loading...
Loading...
SLGC| Name | Value |
|---|---|
| Revenues | 20.4M |
| Cost of Revenue | 12.3M |
| Gross Profit | 8.1M |
| Operating Expense | 48.3M |
| Operating I/L | -40.2M |
| Other Income/Expense | 6.0M |
| Interest Income | 4.9M |
| Pretax | -34.2M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -34.2M |
SomaLogic, Inc. is a US-based company specializing in protein biomarker discovery and clinical diagnostics. It develops slow off-rate modified aptamers (SOMAmers) and offers SomaScan services for multiplex protein detection and quantification in biological samples. The company's technology aids in drug discovery, diagnostic applications for diseases like cardiovascular and metabolic disease, nonalcoholic steatohepatitis, and wellness. SomaLogic serves pharmaceutical and biotechnology companies, academic research institutions, and facilitates drug development, clinical trial analysis, and new human biology insights through protein-protein and protein-gene networks.
